多囊卵巢综合征胰岛素抵抗型中西医治疗研究进展  

Research progress on insulin resistance type of polycystic ovary syndrome in traditional Chinese and western medicine treatment

作　　者：黄进格 王芳[2] 吴元元 何田玉 项瑞君 Huang Jinge;Wang Fang;Wu Yuanyuan;He Tianyu;Xiang Ruijun(Dechang County People's Hospital,Sichuan,Dechang 615500,China;Department of Reproductive Medicine,the Second Hospital of Lanzhou University,Gansu,Lanzhou 730030,China)

机构地区：[1]德昌县人民医院,四川德昌615500 [2]兰州大学第二医院生殖医学科,甘肃兰州730030

出　　处：《发育医学电子杂志》2024年第6期469-475,共7页Journal of Developmental Medicine (Electronic Version)

基　　金：甘肃省功能基因组与分子诊断重点实验室开放课题(054000229);兰州大学第二医院“萃英科技创新”项目(CY2022-MS-B03)。

摘　　要：多囊卵巢综合征(polycystic ovary syndrome,PCOS)是育龄期女性常见的内分泌和代谢疾病之一,其胰岛素抵抗(insulin resistance,IR)是核心病理机制,但目前PCOS-IR的病因、发病机制尚不明确,治疗欠佳,严重影响育龄期女性的身心健康,引起了人们的广泛重视。故本文对PCOS-IR的病因、发病机制及中西医治疗研究等方面进展进行综述,以期为PCOS-IR的发病机制及治疗提供一定的依据。Polycystic ovarian syndrome(PCOS)is one of the common endocrine and metabolic diseases in women of childbearing age.Insulin resistance(IR)is its core pathological mechanism.At present,the etiology and pathogenesis of PCOS-IR are still unclear,and the treatment is poor,which seriously affects the physical and mental health of women of childbearing age,causing widespread attention.Therefore,this article reviews the progress in the etiology,pathogenesis and treatment of PCOS-IR with Chinese and western medicine in order to provide some basis for the pathogenesis and treatment of PCOS-IR.

关 键 词：多囊卵巢综合征 胰岛素抵抗 病因 发病机制 治疗 

分 类 号：R711.75[医药卫生—妇产科学]